Emcure Pharma (EMCURE) — AI Technical & Fundamental Analysis
Detected Patterns
No patterns detected
Key Levels
| Level | Price (₹) |
|---|---|
| Entry | ₹1745.0 |
| Target | ₹1920.0 |
| Stop-Loss | ₹1690.0 |
| Support | ₹1666.58 |
| Resistance | ₹1793.2 |
AI Technical Analysis
{"technical": "Emcure Pharmaceuticals is currently forming a Bull Flag pattern on its 3-month daily chart. The pattern initiated with a sharp, near-vertical pole, rallying over 12% from around \u20b91600 to a 3-month high of \u20b91793.2 within 8 trading sessions. Over the last two weeks, the stock has entered a tight, downward-sloping consolidation channel (the flag), retracing roughly 25% of the preceding pole's gains. This flag formation is accompanied by a visible contraction in daily trading volumes, satisfying the mandatory volume-dry-up condition. The stock is currently trading inside the flag at \u20b91744.6, positioned comfortably above its ascending 20-day SMA (1714.65) and 50-day SMA (1666.58), demonstrating a strong golden cross regime. The RSI-14 has cooled from overbought conditions to a healthy 51.7, resetting momentum without breaking the structural uptrend.", "fundamental": "The company's quarterly financial performance exhibits a strong structural growth trajectory that reinforces the bullish technical setup. Sales have consistently expanded over the last five quarters, rising from \u20b91278 Cr in March 2025 to \u20b91468 Cr in March 2026. This top-line expansion is coupled with a substantial acceleration in profitability; net profit surged from \u20b9140 Cr to \u20b9234 Cr over the same period, peaking at \u20b9259 Cr in December 2025. This robust financial trajectory confirms institutional accumulation and provides fundamental backing for the stock to sustain its current high-momentum swing.", "news": "There is no recent news or corporate announcements available for Emcure Pharmaceuticals. The absence of news indicates that the current chart pattern and price movement are purely driven by technical consensus and organic institutional buying interest, minimizing the risk of sudden, news-driven volatility or sentiment reversals during the swing period.", "pattern_type": "continuation", "momentum_strength": "stable"}
Fundamentals
Incorporated in 1981, Emcure PharmaceuticalsLtd manufactures and markets pharmaceutical products globally[1]
| Quarter | Revenue (Cr) | Net Profit (Cr) |
|---|---|---|
| Mar 2025 | 1278 | 140 |
| Jun 2025 | 1097 | 123 |
| Sep 2025 | 1261 | 118 |
| Dec 2025 | 1418 | 259 |
| Mar 2026 | 1468 | 234 |
Get alerted when EMCURE hits key levels
Set price and news alerts for EMCURE — free on Android.
Download Investonks Free →EMCURE News Alerts Alert History AI Track Record All AI Picks